Cargando…

Potential Biomarkers Associated with Multiple Sclerosis Pathology

Multiple sclerosis (MS) is a complex disease of the central nervous system (CNS) that involves an intricate and aberrant interaction of immune cells leading to inflammation, demyelination, and neurodegeneration. Due to the heterogeneity of clinical subtypes, their diagnosis becomes challenging and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathur, Deepali, Mishra, Bikash Kumar, Rout, Soumyashree, Lopez-Iranzo, Francisco Jose, Lopez-Rodas, Gerardo, Vallamkondu, Jayalakshmi, Kandimalla, Ramesh, Casanova, Bonaventura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508638/ https://www.ncbi.nlm.nih.gov/pubmed/34638664 http://dx.doi.org/10.3390/ijms221910323

Ejemplares similares

Perturbed Glucose Metabolism: Insights into Multiple Sclerosis Pathogenesis
por: Mathur, Deepali, et al.
Publicado: (2014)

Bypassing hazard of housekeeping genes: their evaluation in rat granule neurons treated with cerebrospinal fluid of multiple sclerosis subjects
por: Mathur, Deepali, et al.
Publicado: (2015)

Disturbed Glucose Metabolism in Rat Neurons Exposed to Cerebrospinal Fluid Obtained from Multiple Sclerosis Subjects
por: Mathur, Deepali, et al.
Publicado: (2017)

Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients
por: Mathur, Deepali, et al.
Publicado: (2017)

Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics
por: Kandimalla, Ramesh, et al.
Publicado: (2020)

Liquid Crystals: A Novel Approach for Cancer Detection and Treatment
por: Vallamkondu, Jayalakshmi, et al.
Publicado: (2018)

Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic
por: Dewanjee, Saikat, et al.
Publicado: (2021)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
por: Dewanjee, Saikat, et al.
Publicado: (2021)

SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets
por: Vallamkondu, Jayalakshmi, et al.
Publicado: (2020)

Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
por: Kandimalla, Ramesh, et al.
Publicado: (2021)

Probiotics: Evolving as a Potential Therapeutic Option against Acetaminophen-Induced Hepatotoxicity
por: Dewanjee, Saikat, et al.
Publicado: (2022)

Escalation vs. Early Intense Therapy in Multiple Sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2022)

Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies
por: Ghosh, Nilanjan, et al.
Publicado: (2023)

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges
por: Dewanjee, Saikat, et al.
Publicado: (2021)

Clinical Strategies and Therapeutics for Human Monkeypox Virus: A Revised Perspective on Recent Outbreaks
por: Ghosh, Nilanjan, et al.
Publicado: (2023)

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies
por: Coret, Francisco, et al.
Publicado: (2018)

Preclinical retinal neurodegeneration in a model of multiple sclerosis: The Journal of Neuroscience 2012; 32(16):5585–5597
por: Mathur, Deepali, et al.
Publicado: (2012)

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
por: Anand, Uttpal, et al.
Publicado: (2022)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease
por: Ogunmokun, Gilbert, et al.
Publicado: (2021)

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2017)

From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions
por: Kolb, Hadar, et al.
Publicado: (2022)

Perception of stigma in patients with primary progressive multiple sclerosis
por: Pérez-Miralles, Francisco, et al.
Publicado: (2019)

Biomarkers in Multiple Sclerosis
por: Martin, Roland, et al.
Publicado: (2006)

Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain
por: Landete, Lamberto, et al.
Publicado: (2021)

Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart(®) in patients with multiple sclerosis
por: Edo Solsona, María Dolores, et al.
Publicado: (2017)

CSF Potential Biomarkers Aβ42 and Tau: associations of Apo E Genotype
por: Kandimalla, Ramesh, et al.
Publicado: (2010)

Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers
por: Muñoz, Delicias, et al.
Publicado: (2013)

The role of angiogenesis in the pathology of multiple sclerosis
por: Lengfeld, Justin, et al.
Publicado: (2014)

Multiple sclerosis: Pathology, diagnosis and treatments
por: Huang, Wen-Juan, et al.
Publicado: (2017)

Molecular biomarkers in multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2019)

Digital Biomarkers in Multiple Sclerosis
por: Dillenseger, Anja, et al.
Publicado: (2021)

Protein biomarkers in multiple sclerosis
por: Kim, Jun-Soon
Publicado: (2023)

Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology
por: Calabresi, Peter A., et al.
Publicado: (2010)

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
por: Quintanilla-Bordás, Carlos, et al.
Publicado: (2022)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

Biomarkers in Multiple Sclerosis: Role of Antibodies
por: Berger, Thomas, et al.
Publicado: (2006)

Chemokine Receptors as Biomarkers in Multiple Sclerosis
por: Fox, Robert J., et al.
Publicado: (2006)

Advances in biomarker research in multiple sclerosis
por: Butterworth, Sara E., et al.
Publicado: (2016)

Inflammasome Proteins As Biomarkers of Multiple Sclerosis
por: Keane, Robert W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b3mtg83ki0jh50olr2oc9a3sgc